Granata Bio

Duxbury, MA · Founded 2018 · Privately Held (backing)

Operator of a biopharma company intended to find and grow fertility programs for patients. Granata Bio is based in Duxbury, MA and was founded in 2018. It was valued at $129 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $31.1 million across 2 recorded rounds; the latest was a $13.8 million early-stage round in Dec 2024.

PMV mark · valuation
$129.0M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$31.1M
Last round
Early Stage VC
Dec 2024
What is Granata Bio worth?
$129.0MPrivateMarketView mark · Oct 2026

Valued at $129.0M at its later-stage round, Dec 2024. Nothing has traded since.

Free account
More of Granata Bio with a free account
  • ·Watch Granata Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Granata Bio funding history

2 rounds
DateRoundRaisedPost-money
Dec 2024Early Stage VC$13.8M▮
Oct 2023Early Stage VC$10.1M▮
Unlock post-money valuations

Membership and data by Private Market View

Granata Bio valuation

Granata Bio was valued at $129 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Granata Bio raised?

Granata Bio has raised $31.1 million in total; 2 of its rounds are on record. The largest on record was a $13.8 million early-stage round in Dec 2024.

Granata Bio has filed 2 Form Ds with the SEC since 2023, most recently in Dec 2024 ($13.8 million sold to 3 investors).

How Granata Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Granata Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Granata Bio

What is Granata Bio worth?
Granata Bio is valued at $129.0M as of Oct 2026. Valued at $129.0M at its later-stage round, Dec 2024. Nothing has traded since.
How much has Granata Bio raised?
Granata Bio has raised $31.1M in total funding across 2 recorded rounds.
When did Granata Bio last raise?
Granata Bio last raised in Dec 2024 (Early Stage VC), raising $13.8M.